相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Critical Issues in the Development of Immunotoxins for Anticancer Therapy
Ji-Sun Kim et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2020)
Ebola virus disease
Shevin T. Jacob et al.
NATURE REVIEWS DISEASE PRIMERS (2020)
Recent successes in therapeutics for Ebola virus disease: no time for complacency
Patrick L. Iversen et al.
LANCET INFECTIOUS DISEASES (2020)
Safety, tolerability, pharmacokinetics, and immunogenicity of the therapeutic monoclonal antibody mAb114 targeting Ebola virus glycoprotein (VRC 608): an open-label phase 1 study
Martin R. Gaudinski et al.
LANCET (2019)
Therapeutic strategies to target the Ebola virus life cycle
Thomas Hoenen et al.
NATURE REVIEWS MICROBIOLOGY (2019)
Moxetumomab pasudotox for the treatment of relapsed and/or refractory hairy cell leukemia
Iman Abou Dalle et al.
EXPERT REVIEW OF HEMATOLOGY (2019)
Targeted Diphtheria Toxin-Based Therapy: A Review Article
Fatemeh Shafiee et al.
FRONTIERS IN MICROBIOLOGY (2019)
Bispecific antibodies: Potential immunotherapies for HIV treatment
Giulia Fabozzi et al.
METHODS (2019)
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
Sabue Mulangu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Strategies to Reduce the Immunogenicity of Recombinant Immunotoxins
Ronit Mazor et al.
AMERICAN JOURNAL OF PATHOLOGY (2018)
Virus-Specific T Cells: Broadening Applicability
A. John Barrett et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2018)
The structural basis for filovirus neutralization by monoclonal antibodies
Liam B. King et al.
CURRENT OPINION IN IMMUNOLOGY (2018)
Development of Clinical-Stage Human Monoclonal Antibodies That Treat Advanced Ebola Virus Disease in Nonhuman Primates
Kristen E. Pascal et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Identification of Combinations of Approved Drugs With Synergistic Activity Against Ebola Virus in Cell Cultures
Julie Dyall et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
The Past Need Not Be Prologue: Recommendations for Testing and Positioning the Most-Promising Medical Countermeasures for the Next Outbreak of Ebola Virus Infection
Richard T. Davey et al.
JOURNAL OF INFECTIOUS DISEASES (2018)
Safety, pharmacokinetics, and immunogenicity of a co-formulated cocktail of three human monoclonal antibodies targeting Ebola virus glycoprotein in healthy adults: a randomised, first-in-human phase 1 study
Sumathi Sivapalasingam et al.
LANCET INFECTIOUS DISEASES (2018)
Moxetumomab pasudotox in relapsed/refractory hairy cell leukemia
Robert J. Kreitman et al.
LEUKEMIA (2018)
Quarter Century of Anti-HIV CAR T Cells
Thor A. Wagner
CURRENT HIV/AIDS REPORTS (2018)
Systematic Analysis of Monoclonal Antibodies against Ebola Virus GP Defines Features that Contribute to Protection
Erica Ollmann Saphire et al.
CELL (2018)
Antibody-mediated protection against Ebola virus
Erica Ollmann Saphire et al.
NATURE IMMUNOLOGY (2018)
Ebola virus persistence as a new focus in clinical research
Katie Caviness et al.
CURRENT OPINION IN VIROLOGY (2017)
Repurposing bacterial toxins for intracellular delivery of therapeutic proteins
Greg L. Beilhartz et al.
BIOCHEMICAL PHARMACOLOGY (2017)
The future of antiviral immunotoxins
Katja Spiess et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2016)
Characterization of a re-engineered, mesothelin-targeted Pseudomonas exotoxin fusion protein for lung cancer therapy
Frieder Bauss et al.
MOLECULAR ONCOLOGY (2016)
Structural and molecular basis for Ebola virus neutralization by protective human antibodies
John Misasi et al.
SCIENCE (2016)
Antibody therapeutics for Ebola virus disease
Larry Zeitlin et al.
CURRENT OPINION IN VIROLOGY (2016)
Characterization of Yellow Fever Virus Infection of Human and Non-human Primate Antigen Presenting Cells and Their Interaction with CD4+ T Cells
Yu Cong et al.
PLOS NEGLECTED TROPICAL DISEASES (2016)
Plant Toxin-Based Immunotoxins for Cancer Therapy: A Short Overview
Letizia Polito et al.
BIOMEDICINES (2016)
Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail Antibodies
Edgar Davidson et al.
JOURNAL OF VIROLOGY (2015)
Advances in Anticancer Immunotoxin Therapy
Christine Alewine et al.
ONCOLOGIST (2015)
T cell engineering as therapy for cancer and HIV: our synthetic future
Carl H. June et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2015)
Reversion of advanced Ebola virus disease in nonhuman primates with ZMapp
Xiangguo Qiu et al.
NATURE (2014)
Emergence of Zaire Ebola Virus Disease in Guinea
Sylvain Baize et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Structures of protective antibodies reveal sites of vulnerability on Ebola virus
Charles D. Murin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Nomenclature- and Database-Compatible Names for the Two Ebola Virus Variants that Emerged in Guinea and the Democratic Republic of the Congo in 2014
Jens H. Kuhn et al.
VIRUSES-BASEL (2014)
Therapeutic Intervention of Ebola Virus Infection in Rhesus Macaques with the MB-003 Monoclonal Antibody Cocktail
James Pettitt et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Selective killing of Kaposi's sarcoma-associated herpesvirus lytically infected cells with a recombinant immunotoxin targeting the viral gpK8.1A envelope glycoprotein
Deboeeta Chatterjee et al.
MABS (2012)
The Ebola Virus Glycoprotein Contributes to but Is Not Sufficient for Virulence In Vivo
Allison Groseth et al.
PLOS PATHOGENS (2012)
An immunotoxin targeting the gH glycoprotein of KSHV for selective killing of cells in the lytic phase of infection
Yingyun Cai et al.
ANTIVIRAL RESEARCH (2011)
A guide to taming a toxin - recombinant immunotoxins constructed from Pseudomonas exotoxin A for the treatment of cancer
John E. Weldon et al.
FEBS JOURNAL (2011)
Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus
I-Chueh Huang et al.
PLOS PATHOGENS (2011)
Immunotoxin Complementation of HAART to Deplete Persisting HIV-Infected Cell Reservoirs
Edward A. Berger et al.
PLOS PATHOGENS (2010)
Treatment of hepatocellular carcinoma in a mouse xenograft model with an immunotoxin which is engineered to eliminate vascular leak syndrome
Hao Wang et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Neutralizing antibody fails to impact the course of Ebola virus infection in monkeys
Wendelien B. Oswald et al.
PLOS PATHOGENS (2007)
Effects of Ebola virus glycoproteins on endothelial cell activation and barrier function
VM Wahl-Jensen et al.
JOURNAL OF VIROLOGY (2005)
Pre- and postexposure prophylaxis of Ebola virus infection in an animal model by passive transfer of a neutralizing human antibody
PWHI Parren et al.
JOURNAL OF VIROLOGY (2002)
Ebola virus glycoproteins induce global surface protein down-modulation and loss of cell adherence
G Simmons et al.
JOURNAL OF VIROLOGY (2002)
Downregulation of β1 integrins by Ebola virus glycoprotein:: Implication for virus entry
A Takada et al.
VIROLOGY (2000)
Epitopes involved in antibody-mediated protection from Ebola virus
JA Wilson et al.
SCIENCE (2000)
分享论文
